GlaxoSmithKline (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,388.00p
   
  • Change Today:
    -26.00p
  • 52 Week High: 1,525.80
  • 52 Week Low: 1,190.80
  • Currency: UK Pounds
  • Shares Issued: 5,032m
  • Volume: 6,966,231
  • Market Cap: 69,840m
  • RiskGrade: 129

GlaxoSmithKline Overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 5.8% 5.6%
Div Cover 1.4 1.3
Op Mrgn 22.8% 22.3%
ROCE 66.0%  
Latest F'cast
P/E 12.0 13.7
PEG n/a n/a
Pr/Revenue 2.0 2.1
Pr/Book 3.4  
Latest F'cast
Revenue 1.0% -2.0%
PBT 12.0% 7.1%
EPS -6.5% -12.3%
DPS n/a -2.2%

GlaxoSmithKline Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-16 27,889.00 1,939.00 102.40p 15.3 0.4 +35% 80.00p 5.1%
31-Dec-17 30,186.00 3,525.00 111.80p 11.8 1.3 +9% 80.00p 6.0%
31-Dec-18 30,821.00 4,800.00 119.40p 12.5 1.8 +7% 80.00p 5.4%
31-Dec-19 33,754.00 6,221.00 123.90p 14.4 3.6 +4% 80.00p 4.5%
31-Dec-20 34,099.00 6,968.00 115.90p 11.6 n/a -6% 80.00p 6.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GlaxoSmithKline Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 33,409.13 7,462.11 101.60p 13.7 n/a -12% 78.22p 5.6%
31-Dec-22 35,062.78 8,097.05 111.23p 12.5 1.3 +10% 56.32p 4.1%

Copyright © 2021 FactSet Research Systems Inc. All rights reserved.

GlaxoSmithKline Company Announcements

Director/PDMR Shareholding 24-Sep-2021 17:28 RNS
Director/PDMR Shareholding 22-Sep-2021 15:58 RNS
Director Declaration 20-Sep-2021 14:42 RNS

Latest GlaxoSmithKline Director Deals

Traded Action Notifier PriceAmountValue
09-Sep-21 Transfer From Emma Walmsley 0.000p 9 0.00
09-Sep-21 Buy Emma Walmsley 1,439.30p 9 129.54
07-Sep-21 Buy Hal Barron 1,484.84p 2,443 36,274.63

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,388.00p
Change Today -26.00p
% Change -1.84 %
52 Week High 1,525.80
52 Week Low 1,190.80
Volume 6,966,231
Shares Issued 5,032m
Market Cap 69,840m
RiskGrade 129

GlaxoSmithKline Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
89.08% above the market average89.08% above the market average89.08% above the market average89.08% above the market average89.08% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
45.94% below the market average45.94% below the market average45.94% below the market average45.94% below the market average45.94% below the market average
48.39% below the sector average48.39% below the sector average48.39% below the sector average48.39% below the sector average48.39% below the sector average
Income
89.77% above the market average89.77% above the market average89.77% above the market average89.77% above the market average89.77% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
48.44% above the market average48.44% above the market average48.44% above the market average48.44% above the market average48.44% above the market average
77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average

What The Brokers Say

Strong Buy 7
Buy 2
Neutral 14
Sell 0
Strong Sell 2
Total 25
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  Q2 Q1
Ex-Div 19-Aug-21 20-May-21
Paid 07-Oct-21 08-Jul-21
Amount 19.00p 19.00p

Trades for 24-Sep-2021

Time Volume / Share Price
16:39 20,000 @ 1,388.00p
16:39 8,238 @ 1,388.00p
16:39 679 @ 1,388.00p
16:37 2,049 @ 1,388.00p
16:36 1,982 @ 1,388.00p

GlaxoSmithKline Key Personnel

CEO Emma Walmsley
CFO Iain Mackay

Top of Page